Back to results
US 6,713,491 B2Granted
Heterocyclic derivatives
AssigneeSmithKline Beecham Corporation
InventorAlessandra Orlandi
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel salt of enantiomer A of 7-chloro-4-(2-oxo-1-phenyl-3-pyrrolidinylidene)-1,2,3,4-tetrahydro-2-quinoline carboxylic acid or a solvate thereof, to processes for its preparation, to pharmaceutical compositions containing it and to its use in therapy and in particularly its use as medicine for antagonising the effects of excitatory amino acids upon the NMDA receptor complex.
Claims22
(−) Meglumine salt of 7-chloro-4-(2-oxo-1-phenyl-3-pyrrolidinylidene)-1,2,3,4-tetrahydro-2-quinolinecarboxylic acid.
Dependencies are inferred from the claim text.